KALV Kalvista Pharmaceuticals Inc
KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
$26.17 +0.94 (3.73%)
As of 04/13/2021 15:59:55 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 04/09/2015
Outstanding shares: 24,308,191
Average volume: 425,698
Market cap: $613,295,659
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 483497103
ISIN: US4834971032
Sedol: BD06CS0
Valuation (See tab for details)
PE ratio: -35.25
PB ratio: 7.76
PS ratio: 85.26
Return on equity: -47.53%
Net income %: -386.96%